Yazar "Yıldız, İlkay" için listeleme
-
Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents
Yalçın Özkat, Gözde; Ersan, Ronak H.; Ülger, Mahmut; Ülger, Seda T.; Burmaoğlu, Serdar; Yıldız, İlkay; Algül, Öztekin (Taylor & Francis Ltd., 2022)The increase in the drug-resistant strains of Mycobacterium tuberculosis has led researchers to new drug targets. The development of new compounds that have effective inhibitory properties with the selective vital structure ... -
Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo II alpha
Karataş, Esin; Foto, Egemen; Ertan Bolelli, Tuğba; Yalçın Özkat, Gözde; Yılmaz, Serap; Ataei, Şanaz; Zilifdar, Fatma; Yıldız, İlkay (Elsevier, 2021)Discovery of novel anticancer drugs which have low toxicity and high activity is very significant area in anticancer drug research and development. One of the important targets for cancer treatment research is topoisomerase ... -
In silico studies to develop new GSK3 beta inhibitors effective in the 's disease
Yalçın Özkat, Gözde; Yıldız, İlkay (Bentham Science Publications, 2022)Background: Alzheimer's disease affects a large part of the world's population by prolonging the human life span and becoming an economic burden in the health system. Therefore, its treatment becomes more and more important ... -
In silico studies to develop new GSK3β inhibitors effective in the alzheimer's disease
Yalçın Özkat, Gözde; Yıldız, İlkay (Bentham Science Publishers, 2022)Background: Alzheimer's disease affects a large part of the world’s population by prolonging the human life span and becoming an economic burden in the health system. Therefore, its treatment be-comes more and more important ... -
Synthesis and molecular docking studies of some novel antimicrobial benzamides
Acar, Cemre; Yalçın Özkat, Gözde; Ertan-Bolelli, Tuğba; Onurdağ, Fatma Kaynak; Ökten, Suzan; Şener, Funda; Yıldız, İlkay (Academic Press Inc Elsevier Science, 2020)Common use of classical antibiotics has caused to the growing emergence of many resistant strains of pathogenic bacteria. Therefore, we aimed to synthesize a number of N-(2-hydroxy-(4 or 5)-nitrophenyl)benzamide derivatives ...